| Literature DB >> 24339993 |
Jiao Chen1, Hui Chen, Yun Shi, Feng Hu, Xingzhen Lao, Xiangdong Gao, Heng Zheng, Wenbing Yao.
Abstract
New Delhi metallo-β-lactamase-1 (NDM-1) has attracted extensive attention for its high catalytic activities of hydrolyzing almost all β-lactam antibiotics. NDM-1 shows relatively higher similarity to subclass B1 metallo-β-lactamases (MβLs), but its residue at position 229 is identical to that of B2/B3 MβLs, which is a Tyr instead of a B1-MβL-conserved Trp. To elucidate the possible role of Y229 in the bioactivity of NDM-1, we performed mutagenesis study and molecular dynamics (MD) simulations. Although residue Y229 is spatially distant from the active site and not contacting directly with the substrate or zinc ions, the Y229W mutant was found to have higher kcat and Km values than those of wild-type NDM-1, resulting in 1 ∼ 7 fold increases in k(cat) /K(m) values against tested antibiotics. In addition, our MD simulations illustrated the enhanced flexibility of Loop 2 upon Y229W mutation, which could increase the kinetics of both substrate entrance (kon) and product egress (koff). The enhanced flexibility of Loop 2 might allow the enzyme to adjust the geometry of its active site to accommodate substrates with different structures, broadening its substrate spectrum. This study indicated the possible role of the residue at position 229 in the evolution of NDM-1.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24339993 PMCID: PMC3858288 DOI: 10.1371/journal.pone.0082080
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The sequence alignment of MβLs around position 244 (BBL number), parallel with position 229 in NDM-1.
Kinetic parameters of the wild-type NDM-1 and the Y229W mutant.
| Antibiotics | Wild-type NDM-1 | Y229W mutant | ||||
|
|
|
|
|
|
| |
| (µM) | (s−1) | (s−1/µM) | (µM) | (s−1) | (s−1/µM) | |
| Penicillin G | 178±55 | 34±1.5 | 0.19 | 737±52 | 849±28 | 1.15 |
| Ampicillin | 193±63 | 139±5 | 0.72 | 297±43 | 253±13 | 0.85 |
| Cefuroxime | 17±2 | 6.5±0.3 | 0.38 | 27±3 | 75±6 | 2.78 |
| Ceftizoxime | 21±5 | 3.9±0.3 | 0.18 | 101±25 | 53±3 | 0.52 |
| Meropenem | 59±2 | 35±2 | 0.59 | 268±15 | 435±82 | 1.62 |
MICs (µg/ml) for E.coli BL21 (DE3) host strain harboring the wild-type NDM-1 and Y229W enzymes.
| Enzymes harbored in | Antibiotics (µg/ml) | |||||
| Penicillin G | Ampicillin | Cefuroxime | Ceftizoxime | Meropenem | ||
| Wild-type NDM-1 | >256 | >256 | 256 | 64 | 16 | |
| Y229W mutant | 256 | 128 | 128 | 8 | 8 | |
Figure 2The interactions around Y229 and the active site residues of NDM-1.
Figure 3Distinct conformations of Loop 2 obtained by clustering the MD trajectory of the enzymes.
(A) Superimposition of wild-type NDM-1; (B) Superimposition of Y229W mutant. (C) and (D) are the time evolution of the RMSDs and RMSFs of NDM-1 (black curve) and Y229W mutant (red curve) measured against the corresponding starting structures.
Hydrogen bonds existing in Loop 2 (residues from 214 to 229) of wild-type NDM-1 and Y229W mutant, and their occupancies during the last 4 ns of MD simulations.
| NDM-1 | Y229W mutant | ||||
| Donor | Acceptor | Occupancy (%) | Donor | Acceptor | Occupancy (%) |
|
|
| 84.14 |
|
| 88.96 |
|
|
| 90.19 |
|
| 98.06 |
|
|
| 99.55 |
|
| 98.00 |
|
|
| 99.76 | —— | —— | —— |
|
|
| 98.04 | —— | —— | —— |
|
|
| 85.64 | —— | —— | —— |
| —— | —— | —— |
|
| 55.38 |
| —— | —— | —— |
|
| 53.72 |
|
|
| 99.10 | —— | —— | —— |
|
|
| 99.43 | —— | —— | —— |
|
|
| 99.45 | —— | —— | —— |
| —— | —— | —— |
|
| 85.96 |
| —— | —— | —— |
|
| 57.93 |
|
|
| 96.63 |
|
| 98.58 |
|
|
| 60.30 | —— | —— | —— |
|
|
| 99.83 |
|
| 98.75 |
|
|
| 93.83 |
|
| 96.86 |
Only H-bonds with occupancies >50% are shown.
—— Not observed.
Figure 4The central structure of the major cluster in the last 4 ns of (A) wild-type NDM-1 complexed with hydrolyzed Ampicillin, (B) Y229W mutant complexed with hydrolyzed Ampicillin.
The time evolution of (C) RMSDs and (D) RMSFs of wild-type NDM-1 (black curve) and Y229W mutant (red curve), measured against the corresponding starting structures.
Figure 5Surface representation of the central structure in the major cluster of the last 4 ns, showing the binding groove for substrates in (A) wild-type NDM-1, (B) Y229W mutant.
The binding free energies (hydrolyzed Ampicillin as the substrate) calculated by the MM-PBSA and MM-GBSA method.
| Enzyme | Binding free energy model | ΔGgas | ΔGsolv | ΔG |
| (kcal/mol) | (kcal/mol) | (kcal/mol) | ||
| NDM-1 | MM/PBSA | −124.82 | 96.77 | −28.05 |
| MM/GBSA | −124.82 | 75.29 | −49.53 | |
| Y229W | MM/PBSA | −72.29 | 57.51 | −14.78 |
| MM/GBSA | −72.29 | 52.80 | −19.49 |